Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.01
Delayed Data
As of 1:00pm ET
 +0.03 / +1.52%
Today’s Change
1.74
Today|||52-Week Range
3.15
-2.90%
Year-to-Date
No recent news for Geron Corp.

Today’s Trading

Previous close1.98
Today’s open1.96
Day’s range1.93 - 2.01
Volume563,019
Average volume (3 months)1,185,798
Market cap$315.3M
Dividend yield--
Data as of 1:00pm ET, 11/24/2017

Growth & Valuation

Earnings growth (last year)-63,433.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-83.06%
P/E ratioNM
Price/Sales53.43
Price/Book2.58

Competitors

 Today’s
change
Today’s
% change
BTXBioTime Inc+0.11+4.33%
BLCMBellicum Pharmaceuti...-0.02-0.20%
EDGEEdge Therapeutics In...+0.14+1.41%
AGENAgenus Inc-0.10-2.49%
Data as of 4:00pm ET, 11/24/2017

Financials

Next reporting dateMarch 7, 2018
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$6.2M
Annual profit (last year)-$29.5M
Net profit margin-479.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts